Gateway Investment Advisers LLC Regeneron Pharmaceuticals, Inc. Transaction History

Gateway Investment Advisers LLC

  • $9 Billion
  • Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 1,113 shares of REGN stock, worth $792,901. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,113
Previous 947 17.53%
Holding current value
$792,901
Previous $995,000 17.59%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
BUY
$1024.09 - $1201.76 $169,998 - $199,492
166 Added 17.53%
1,113 $1.17 Million
Q2 2024

Jul 12, 2024
SELL
$883.2 - $1071.19 $344,448 - $417,764
-390 Reduced 29.17%
947 $995,000
Q1 2024

Apr 12, 2024
BUY
$902.69 - $993.35 $145,333 - $159,929
161 Added 13.69%
1,337 $1.29 Million
Q4 2023

Jan 09, 2024
BUY
$775.18 - $881.7 $231,778 - $263,628
299 Added 34.09%
1,176 $1.03 Million
Q3 2023

Oct 19, 2023
SELL
$692.45 - $844.37 $26,313 - $32,086
-38 Reduced 4.15%
877 $721,000
Q2 2023

Jul 13, 2023
SELL
$700.03 - $830.35 $40,601 - $48,160
-58 Reduced 5.96%
915 $657,000
Q1 2023

Apr 11, 2023
SELL
$680.49 - $826.97 $19,053 - $23,155
-28 Reduced 2.8%
973 $799,000
Q4 2022

Jan 13, 2023
BUY
$705.89 - $766.39 $64,235 - $69,741
91 Added 10.0%
1,001 $0
Q3 2022

Oct 07, 2022
SELL
$573.97 - $724.32 $35,586 - $44,907
-62 Reduced 6.38%
910 $627,000
Q2 2022

Jul 13, 2022
BUY
$548.35 - $738.84 $11,515 - $15,515
21 Added 2.21%
972 $575,000
Q1 2022

Apr 14, 2022
SELL
$595.12 - $698.43 $91,053 - $106,859
-153 Reduced 13.86%
951 $664,000
Q4 2021

Jan 14, 2022
SELL
$543.48 - $670.97 $13,043 - $16,103
-24 Reduced 2.13%
1,104 $697,000
Q3 2021

Oct 22, 2021
SELL
$574.03 - $680.96 $14,350 - $17,024
-25 Reduced 2.17%
1,128 $683,000
Q2 2021

Jul 13, 2021
SELL
$472.8 - $558.54 $25,531 - $30,161
-54 Reduced 4.47%
1,153 $644,000
Q1 2021

Apr 14, 2021
BUY
$446.73 - $548.2 $17,869 - $21,928
40 Added 3.43%
1,207 $571,000
Q4 2020

Jan 14, 2021
SELL
$478.3 - $607.98 $15,783 - $20,063
-33 Reduced 2.75%
1,167 $564,000
Q3 2020

Oct 19, 2020
SELL
$544.75 - $658.21 $50,117 - $60,555
-92 Reduced 7.12%
1,200 $672,000
Q2 2020

Jul 15, 2020
BUY
$493.32 - $643.92 $3,946 - $5,151
8 Added 0.62%
1,292 $806,000
Q1 2020

Apr 13, 2020
BUY
$336.18 - $494.43 $93,458 - $137,451
278 Added 27.63%
1,284 $627,000
Q4 2019

Jan 09, 2020
SELL
$274.13 - $376.51 $61,679 - $84,714
-225 Reduced 18.28%
1,006 $378,000
Q3 2019

Oct 15, 2019
SELL
$273.46 - $318.39 $577,274 - $672,121
-2,111 Reduced 63.17%
1,231 $341,000
Q2 2019

Jul 17, 2019
SELL
$299.6 - $414.82 $68,608 - $94,993
-229 Reduced 6.41%
3,342 $1.05 Million
Q1 2019

Apr 10, 2019
BUY
$372.08 - $439.57 $84,090 - $99,342
226 Added 6.76%
3,571 $1.47 Million
Q4 2018

Jan 14, 2019
BUY
$335.82 - $403.04 $7,723 - $9,269
23 Added 0.69%
3,345 $1.25 Million
Q3 2018

Oct 16, 2018
SELL
$351.14 - $408.51 $16,854 - $19,608
-48 Reduced 1.42%
3,322 $1.34 Million
Q2 2018

Jul 11, 2018
SELL
$284.6 - $344.99 $327,005 - $396,393
-1,149 Reduced 25.43%
3,370 $1.16 Million
Q1 2018

Apr 12, 2018
SELL
$315.82 - $393.78 $106,747 - $133,097
-338 Reduced 6.96%
4,519 $1.56 Million
Q4 2017

Jan 17, 2018
SELL
$358.63 - $469.95 $121,575 - $159,313
-339 Reduced 6.52%
4,857 $1.83 Million
Q3 2017

Oct 16, 2017
BUY
$431.38 - $504.0 $2.24 Million - $2.62 Million
5,196
5,196 $2.32 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.4B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email